Loading stock data…
Smith & Nephew SNATS, Inc. (SNN)
$30.57+0.80 (+2.69%)
Market ClosedLast close Jul 24
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Smith & Nephew plc in the Healthcare sector is trading at $30.57 with a market capitalization of $12.7B. Wall Street consensus targets $34.07 (5 analysts), implying a +11.5% move over the next 12 months. The stock is currently near its 52-week low of $28.56, remaining 6.0% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +11.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Me...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$12.72B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
20.93
Beta
Defensive asset. Lower volatility than the S&P 500.
0.67
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.55%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
1.17M
Recent News
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
European equities traded in the US as American depositary receipts were tracking higher late Friday
Smith+Nephew Expands ASC Platform to Support Value-Based Care
SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.
Alkami Technology, Diebold Nixdorf, and 3 More Stocks See Action From Activist Investors.
Activist investors report to the SEC on Alkami Technology, Smith & Nephew, Navigator Holdings, Diebold Nixdorf, and Kymera Therapeutics.
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
European equities traded in the US as American depositary receipts were heading higher late Tuesday